Animal models for autoimmune liver disease - What is relevant for immune-mediated liver disease

Digestive Diseases

Volumn 30, Issue SUPPL. 1, 2012, Pages 2-10

  Hardtke Wolenski, Matthias ^a   Taubert, Richard ^a   Jaeckel, Elmar ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Autoimmune hepatitis; Mouse model; Pathophysiology

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; CYTOKINE; STEROID;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL MODEL; ARTICLE; AUTOIMMUNE HEPATITIS; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CHRONIC DISEASE; DISEASE COURSE; DISEASE SEVERITY; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CELL; LIVER FUNCTION; LIVER INJURY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC ANIMAL; UNSPECIFIED SIDE EFFECT;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION; LIVER DISEASES; T-LYMPHOCYTES;

EID: 84867712595     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000341114     Document Type: Article

References (78)

1. Calne RY, et al: Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-476.
2. Qian S, et al: Murine liver allograft transplantation: Tolerance and donor cell chimerism. Hepatology 1994; 19: 916-924. (Pubitemid 24109354)
3. Kamada N: The immunology of experimental liver transplantation in the rat. Immunology 1985; 55: 369-389. (Pubitemid 15058228)
4. Alvarez F, et al: International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938. (Pubitemid 29514229)
5. Ichiki Y, et al: Is primary biliary cirrhosis a model autoimmune disease? Autoimmun Rev 2004; 3: 331-336. (Pubitemid 38887629)
6. Park BK, Kitteringham NR: Drug-protein conjugation and its immunological consequences. Drug Metab Rev 1990; 22: 87-144. (Pubitemid 20211495)
7. Nelson SD, Pearson PG: Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu Rev Pharmacol Toxicol 1990; 30: 169-195.
8. Bowen DG, et al: The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004; 114: 701-712. (Pubitemid 39578761)
9. Shibolet O, et al: The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation. Clin Immunol 2004; 111: 82-92. (Pubitemid 38482085)
10. Limmer A, et al: Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific Tcell tolerance. Nat Med 2000; 6: 1348-1354. (Pubitemid 32001018)
11. Crispe IN: Hepatic T cells and liver tolerance. Nat Rev Immunol 2003; 3: 51-62. (Pubitemid 37328699)
12. Chen CH, et al: In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 2006; 44: 1171-1181.
13. Schildberg FA, et al: Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism. Hepatology 2010; 54: 262-272.
14. Lüth S, et al: Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 2008; 118: 3403-3410.
15. Czaja AJ, et al: Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 1993; 105: 1502-1507. (Pubitemid 23315327)
16. Czaja AJ, et al: Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology 1993; 18: 816-822.
17. Oliveira LC, et al: Autoimmune hepatitis, HLA and extended haplotypes. Autoimmun Rev 10: 189-193.
18. Agarwal K, et al: Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 2000; 31: 49-53. (Pubitemid 30033688)
19. Djilali-Saiah I, et al: CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis. Hum Immunol 2001; 62: 1356-1362. (Pubitemid 33116973)
20. Windhagen A, et al: Altered CD45 isoform expression in C77G carriers influences cytokine responsiveness and adhesion properties of T cells. Clin Exp Immunol 2007; 150: 509-517. (Pubitemid 350098732)
21. Cookson S, et al: Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999; 30: 851-856. (Pubitemid 29458270)
22. Diamantis I, Boumpas DT: Autoimmune hepatitis: Evolving concepts. Autoimmun Rev 2004; 3: 207-214. (Pubitemid 38521096)
23. Ichiki Y, et al: T cell immunity in autoimmune hepatitis. Autoimmun Rev 2005; 4: 315-321. (Pubitemid 40884551)
24. Tiegs G, Hentschel J, Wendel A: A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992; 90: 196-203.
25. Tiegs G: Experimental hepatitis and role of cytokines. Acta Gastroenterol Belg 1997; 60: 176-179. (Pubitemid 27305269)
26. Gantner F, et al: T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp Cell Res 1996; 229: 137-146. (Pubitemid 26423942)
27. Kusters S, et al: Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996; 111: 462-471. (Pubitemid 26256736)
28. Gantner F, et al: Concanavalin A-induced Tcell-mediated hepatic injury in mice: The role of tumor necrosis factor. Hepatology 1995; 21: 190-198.
29. Knolle PA, et al: Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice. Hepatology 1996; 24: 824-829. (Pubitemid 26334281)
30. Swain MG: Hepatic NKT cells: Friend or foe? Clin Sci (Lond) 2008; 114: 457-466. (Pubitemid 351548754)
31. Takeda K, et al: Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000; 97: 5498-5503. (Pubitemid 30313747)
32. Erhardt A, et al: IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 2007; 45: 475-485. (Pubitemid 46374604)
33. Ye F, et al: Tr1 regulatory T cells induced by ConA pretreatment prevent mice from ConA-induced hepatitis. Immunol Lett 2009; 122: 198-207.
34. Shull MM, et al: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693-699.
35. Gorham JD, et al: Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol 2001; 166: 6413-6422. (Pubitemid 32440776)
36. Nishimura H, et al: Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001; 291: 319-322. (Pubitemid 32096320)
37. Kido M, et al: Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling. Gastroenterology 2008; 135: 1333-1343.
38. Aoki N, et al: Dysregulated generation of follicular helper T cells in the spleen triggers fatal autoimmune hepatitis in mice. Gastroenterology 140: 1322-1333.e1-e5.
39. Kuriki J, et al: Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae . Gastroenterology 1983; 84: 596-603. (Pubitemid 13191914)
40. Scheiffarth F, Warnatz H, Mayer K: Studies concerning the importance of mononuclear cells in the development of experimental hepatitis. J Immunol 1967; 98: 396-401.
41. Watanabe Y, et al: Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice. Clin Exp Immunol 1987; 67: 105-113. (Pubitemid 17222167)
42. Mori T, et al: Cell-mediated cytotoxicity of sensitized spleen cells against target liver cells -in vivo and in vitro study with a mouse model of experimental autoimmune hepatitis. Hepatology 1985; 5: 770-777. (Pubitemid 15236620)
43. Mori Y, et al: Study of cellular immunity in experimental autoimmune hepatitis in mice: Transfer of spleen cells sensitized with liver proteins. Clin Exp Immunol 1985; 61: 577-584. (Pubitemid 16252334)
44. Mori Y, et al: Study of cellular immunity in experimental autoimmune hepatitis in mice. Clin Exp Immunol 1984; 57: 85-92. (Pubitemid 14083831)
45. Lohse AW, et al: Autoantibodies in experimental autoimmune hepatitis. J Hepatol 1992; 14: 48-53.
46. Lohse AW, Kogel M, Meyer zum Buschenfelde KH: Evidence for spontaneous immunosuppression in autoimmune hepatitis. Hepatology 1995; 22: 381-388.
47. Lohse AW, et al: Experimental autoimmune hepatitis: Disease induction, time course and T-cell reactivity. Hepatology 1990; 11: 24-30. (Pubitemid 20075097)
48. Lohse AW, Meyer zum Buschenfelde KH: Remission of experimental autoimmune hepatitis is associated with antigen-specific and non-specific immunosuppression. Clin Exp Immunol 1993; 94: 163-167. (Pubitemid 23308383)
49. Derbinski J, et al: Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001; 2: 1032-1039. (Pubitemid 33069498)
50. Klein L, et al: CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med 1998; 188: 5-16. (Pubitemid 28328601)
51. Klein L, Kyewski B: 'Promiscuous' expression of tissue antigens in the thymus: A key to T-cell tolerance and autoimmunity? J Mol Med 2000; 78: 483-494.
52. Jones-Youngblood SL, et al: Effect of the expression of a hepatocyte-specific MHC molecule in transgenic mice on T cell tolerance. J Immunol 1990; 144: 1187-1195. (Pubitemid 20072882)
53. Wieties K, et al: Peripheral tolerance in mice expressing a liver-specific class I molecule: Inactivation/deletion of a T-cell subpopulation. Proc Natl Acad Sci USA 1990; 87: 6604-6608.
54. Morahan G, et al: Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci USA 1989; 86: 3782-3786. (Pubitemid 19141829)
55. Moriyama T, et al: Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 1990; 248: 361-364.
56. Chisari FV, Ferrari C: Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60.
57. Chisari FV: Hepatitis B virus transgenic mice: Models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol 1996; 206: 149-173. (Pubitemid 26025611)
58. Wirth S, et al: Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice. J Immunol 1995; 154: 2504-2515.
59. Shimizu Y, et al: Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 1998; 161: 4520-4529. (Pubitemid 28492022)
60. Mix H, et al: Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology 2008; 135: 2107-2118.
61. Benseler V, et al: Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci USA 2011; 108: 16735-16740.
62. Holz LE, et al: CD8+ T cell tolerance following antigen recognition on hepatocytes. J Autoimmun 2010; 34: 15-22.
63. Holz LE, et al: Intrahepatic murine CD8 Tcell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology 2008; 135: 989-997.
64. Voehringer D, et al: Break of T cell ignorance to a viral antigen in the liver induces hepatitis. J Immunol 2000; 165: 2415-2422. (Pubitemid 30660685)
65. Buxbaum J, et al: Hepatitis resulting from liver-specific expression and recognition of self-antigen. J Autoimmun 2008; 31: 208-215.
66. Derkow K, et al: Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis. Hepatology 2007; 46: 1155-1165. (Pubitemid 350144780)
67. Zierden M, Odenthal EK, Dienes HP: Effects and regulation of autoreactive CD8(+) T cells in a transgenic mouse model of autoimmune hepatitis. Gastroenterology 2010.
68. Schurich A, et al: Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells. J Immunol 2010; 184: 4107-4114.
69. Knolle PA, et al: Induction of cytokine production in naive CD4(+) T cells by antigenpresenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 1999; 116: 1428-1440. (Pubitemid 29258892)
70. Lohse AW, et al: Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 1996; 110: 1175-1181. (Pubitemid 26113757)
71. Thomson AW, Knolle PA: Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 10: 753-766.
72. Holdener M, et al: Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med 2008; 205: 1409-1422. (Pubitemid 351831496)
73. Lapierre P, et al: A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens. Hepatology 2004; 39: 1066-1074. (Pubitemid 38428946)
74. Fischer K, et al: A new animal model of chronic autoimmune hepatitis mediated by the adaptive immune system (abstract). Z Gastroenterol 2009; 47: 151.
75. Autschbach F, et al: Hepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis. Hepatology 1991; 14: 223-230.
76. Lobo-Yeo A, et al: Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis. Clin Exp Immunol 1987; 67: 95-104. (Pubitemid 17222166)
77. Ma Y, et al: Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 2006; 130: 868-882. (Pubitemid 43374534)
78. Longhi MS, et al: Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology 2007; 46: 472-484. (Pubitemid 47344783)